The FDA says the Azempic from Ozempic.

The American Food and Medical Management of Ozempic and Wegovy said that glp-1 drugs for diabetes and weight loss drugs were no longer a short support. CBS News Reporter Ali Baumban reports whether the supply change can pay more consumers.